hero section gradient
15 handpicked stocks

Water Wars Portfolio

Dive into companies transforming how we access, purify, and manage Earth's most precious resource. These carefully selected stocks represent leaders revolutionizing water technology and infrastructure as global demand surges.

Author avatar

Han Tan | Market Analyst

Published on June 17

Your Basket's Financial Footprint

Concise analysis of total market capitalisation and concentration by large-cap positions in the Water Wars Portfolio.

Key Takeaways for Investors:
  • Large-cap dominance generally implies more stability and lower volatility, so performance tends to track the broader market.
  • Suitable as a core portfolio holding for steady exposure, not as a speculative or tactical growth trade.
  • Expect steady, long-term value accumulation rather than rapid, short-term explosive gains.
Total Market Cap
  • XYL: $35.83B

  • AWK: $28.13B

  • WTRG: $11.69B

  • Other

About This Group of Stocks

1

Our Expert Thinking

Water scarcity represents one of the greatest investment opportunities of our time. As climate change and population growth strain limited resources, companies providing water solutions are positioned for sustained growth. This portfolio captures the entire water value chain from utilities to cutting-edge purification technology.

2

What You Need to Know

This collection offers exposure to a necessity-based sector with defensive characteristics and growth potential. Water stocks tend to be less volatile than broader markets while benefiting from essential infrastructure spending. The aging water systems worldwide require trillions in upgrades over coming decades.

3

Why These Stocks

Each company was selected for its direct operational involvement in water management, from large utilities with stable regulated returns to specialized technology firms pioneering efficiency solutions. These businesses are uniquely positioned to address the growing imbalance between fixed supply and rising global demand.

Why You'll Want to Watch These Stocks

💧

Liquid Gold Opportunity

Water is becoming more valuable than oil in many regions. These companies control access to what may become the most profitable commodity of the 21st century.

🌊

Trillion-Dollar Infrastructure Wave

The global water crisis is forcing massive investment in new infrastructure. These companies are first in line for contracts worth trillions over the coming decades.

🛡️

Recession-Resistant Returns

Need water? So does everyone else. These essential service providers offer stability when markets get choppy, with consistent demand regardless of economic conditions.

Get the full story on this Basket. Read our detailed article on its risks and potential.

Read Full Insight

Why Invest with Nemo Money?

Nemo Logo Fade
🆓

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

🔒

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

💰

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Discover More Opportunities

Tech Stocks (AI Valuation Reset) Present Potential Entry

Tech Stocks (AI Valuation Reset) Present Potential Entry

Recent market turmoil, driven by concerns over AI stock valuations, has led to a significant drop in global markets. This correction creates a potential opportunity to invest in fundamentally sound technology companies at more attractive prices.

Walmart Succession Plan Explained | Market Effects

Walmart Succession Plan Explained | Market Effects

Walmart announced a CEO transition, with veteran John Furner taking the helm, which could create opportunities for competitors. This leadership change at a retail giant may cause short-term uncertainty, potentially benefiting other major players in the retail space.

Biotech Buyout Candidates (Post-Merck Acquisition)

Biotech Buyout Candidates (Post-Merck Acquisition)

Merck's $9.2 billion acquisition of Cidara Therapeutics for its antiviral drug pipeline signals a broader industry trend. This creates an investment opportunity in other biotech companies with promising late-stage drugs that could become the next acquisition targets for pharmaceutical giants.

Frequently Asked Questions